US3758475A
(en)
|
1971-07-20 |
1973-09-11 |
Sandoz Ag |
Pyrido(2,3-d)pyrimidin 2 ones
|
IT1226048B
(it)
|
1981-12-14 |
1990-12-10 |
Medea Res Srl |
Composti ad attivita'antiinfiammatoria, processo per la loro preparazione e composizioni farmaceutiche relative
|
EP0081756B1
(fr)
|
1981-12-14 |
1985-05-15 |
MEDEA RESEARCH S.r.l. |
Composés ayant une activité anti-inflammatoire et anti-tussive, procédé pour leur préparation et compositions pharmaceutiques les contenant
|
US4501729A
(en)
|
1982-12-13 |
1985-02-26 |
Research Corporation |
Aerosolized amiloride treatment of retained pulmonary secretions
|
EP0278374A3
(fr)
*
|
1987-02-06 |
1989-03-01 |
Pharmatest Apparatebau Gmbh |
Dispositif de détermination de la libération de composants actifs par des produits pharmaceutiques
|
US5981714A
(en)
|
1990-03-05 |
1999-11-09 |
Genzyme Corporation |
Antibodies specific for cystic fibrosis transmembrane conductance regulator and uses therefor
|
JP3167762B2
(ja)
|
1990-11-27 |
2001-05-21 |
武田薬品工業株式会社 |
ピリドピリダジン誘導体およびその用途
|
US5612360A
(en)
|
1992-06-03 |
1997-03-18 |
Eli Lilly And Company |
Angiotensin II antagonists
|
CA2107196A1
(fr)
|
1992-09-29 |
1994-03-30 |
Mitsubishi Chemical Corporation |
Derives de carboxamide
|
US6060024A
(en)
*
|
1993-07-14 |
2000-05-09 |
Zymark Corporation |
Automatic dissolution testing system
|
GB9317764D0
(en)
|
1993-08-26 |
1993-10-13 |
Pfizer Ltd |
Therapeutic compound
|
DE69416848T2
(de)
|
1993-10-21 |
1999-07-08 |
Searle & Co |
Amidino-derivate als no-synthetase inhibitoren
|
DE4405712A1
(de)
|
1994-02-23 |
1995-08-24 |
Basf Ag |
Substituierte Naphthyridine und deren Verwendung
|
NO305987B1
(no)
|
1994-04-11 |
1999-08-30 |
Sankyo Co |
Heterosykliske forbindelser med antidiabetisk aktivitet, deres anvendelse og farmasoeytisk preparat inneholdende disse
|
JP3953097B2
(ja)
|
1994-09-27 |
2007-08-01 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
N−置換ピペリジニル二環式ベンゾエート誘導体
|
JP3688713B2
(ja)
*
|
1994-10-28 |
2005-08-31 |
ソフィオン バイオサイエンス アクティーゼルスカブ |
高処理量及び低流体容積要件を有するパッチ固定装置及び方法
|
US5656256A
(en)
|
1994-12-14 |
1997-08-12 |
The University Of North Carolina At Chapel Hill |
Methods of treating lung disease by an aerosol containing benzamil or phenamil
|
US5510379A
(en)
|
1994-12-19 |
1996-04-23 |
Warner-Lambert Company |
Sulfonate ACAT inhibitors
|
WO1997036876A1
(fr)
|
1996-04-03 |
1997-10-09 |
Merck & Co., Inc. |
Inhibiteurs de la farnesyl-proteine transferase
|
ES2176776T3
(es)
|
1996-08-23 |
2002-12-01 |
Agouron Pharma |
Ligandos del neuropeptido-y.
|
WO1998028980A1
(fr)
|
1996-12-30 |
1998-07-09 |
Merck & Co., Inc. |
Inhibiteurs de farnesyl-proteine transferase
|
US5948814A
(en)
|
1997-02-20 |
1999-09-07 |
The Curators Of The University Of Missouri |
Genistein for the treatment of cystic fibrosis
|
WO1998047868A1
(fr)
|
1997-04-18 |
1998-10-29 |
Smithkline Beecham Plc |
Derives d'uree contenant un heterocycle utilises comme antagonistes des recepteurs 5ht1a, 5ht1b et 5ht¿1d?
|
KR20010030881A
(ko)
|
1997-10-02 |
2001-04-16 |
가와무라 요시부미 |
아미도카르복실산 유도체
|
DE69914458T2
(de)
|
1998-02-17 |
2004-10-28 |
G.D. Searle & Co., Chicago |
Verfahren zur enzymatischen auflösung von laktamen
|
JP2002517483A
(ja)
|
1998-06-08 |
2002-06-18 |
シェーリング コーポレイション |
神経ペプチドy5レセプターアンタゴニスト
|
US6426331B1
(en)
|
1998-07-08 |
2002-07-30 |
Tularik Inc. |
Inhibitors of STAT function
|
AUPP609198A0
(en)
|
1998-09-22 |
1998-10-15 |
Curtin University Of Technology |
Use of non-peptidyl compounds for the treatment of insulin related ailments
|
KR20010101287A
(ko)
|
1998-12-18 |
2001-11-14 |
블레어 큐. 퍼거슨 |
케모킨 수용체 활성의 조절자로서 n-우레이도알킬-피페리딘
|
AU772446B2
(en)
|
1999-02-24 |
2004-04-29 |
F. Hoffmann-La Roche Ag |
3-phenylpyridine derivatives and their use as NK-1 receptor antagonists
|
WO2000050398A2
(fr)
|
1999-02-24 |
2000-08-31 |
F. Hoffmann-La Roche Ag |
Derives de pyridinyl et de phenyle
|
EP1035115B1
(fr)
|
1999-02-24 |
2004-09-29 |
F. Hoffmann-La Roche Ag |
Dérivés de 4-phenylpyridine et leur utilisation comme antagonistes du recepteur NK-1
|
UA71971C2
(en)
|
1999-06-04 |
2005-01-17 |
Agoron Pharmaceuticals Inc |
Diaminothiazoles, composition based thereon, a method for modulation of protein kinases activity, a method for the treatment of diseases mediated by protein kinases
|
BR0012291A
(pt)
|
1999-06-18 |
2002-03-26 |
Bayer Ag |
Fenoxifluorpirimidinas
|
UA74539C2
(en)
|
1999-12-08 |
2006-01-16 |
Pharmacia Corp |
Crystalline polymorphous forms of celecoxib (variants), a method for the preparation thereof (variants), a pharmaceutical composition (variants)
|
WO2001046165A2
(fr)
|
1999-12-16 |
2001-06-28 |
Novartis Ag |
Composes organiques
|
CA2396079A1
(fr)
|
2000-01-07 |
2001-07-19 |
Transform Pharmaceuticals, Inc. |
Formation, identification et analyse a productivites elevees de formes solides diverses
|
US7122309B2
(en)
*
|
2000-01-15 |
2006-10-17 |
Avigenics, Inc. |
High throughput screening assay for detecting a DNA sequence
|
WO2001054690A1
(fr)
|
2000-01-28 |
2001-08-02 |
Biogen, Inc. |
Compositions pharmaceutiques contenant des composes d'integrine anti-beta 1 et utilisations correspondantes
|
US20020065303A1
(en)
|
2000-02-01 |
2002-05-30 |
Bing-Yan Zhu |
Bivalent phenylene inhibitors of factor Xa
|
AU2001249417A1
(en)
|
2000-04-26 |
2001-11-07 |
Gliatech, Inc. |
Chiral imidazoyl intermediates for the synthesis of 2-(4-imidazoyl)-cyclopropyl derivatives
|
WO2001083517A1
(fr)
|
2000-05-03 |
2001-11-08 |
Tularik Inc. |
Derives de dipeptides de liaison stat4 et stat6
|
US6499984B1
(en)
|
2000-05-22 |
2002-12-31 |
Warner-Lambert Company |
Continuous production of pharmaceutical granulation
|
WO2001092235A1
(fr)
|
2000-06-01 |
2001-12-06 |
Bristol-Myers Squibb Pharma Company |
Lactames substitues par des succinates cycliques en tant qu'inhibiteurs de la production de la proteine beta
|
TWI259180B
(en)
|
2000-08-08 |
2006-08-01 |
Hoffmann La Roche |
4-Phenyl-pyridine derivatives
|
CA2422367C
(fr)
|
2000-09-15 |
2010-05-18 |
Vertex Pharmaceuticals Incorporated |
Composes de pyrazole pouvant etre utilises comme inhibiteurs de la proteine kinase
|
JP4272338B2
(ja)
|
2000-09-22 |
2009-06-03 |
バイエル アクチェンゲゼルシャフト |
ピリジン誘導体
|
AU2002211379A1
(en)
|
2000-10-04 |
2002-04-15 |
The Children's Hospital Of Philadelphia |
Compositions and methods for treatment of cystic fibrosis
|
GB2367816A
(en)
|
2000-10-09 |
2002-04-17 |
Bayer Ag |
Urea- and thiourea-containing derivatives of beta-amino acids
|
ATE269856T1
(de)
|
2000-10-20 |
2004-07-15 |
Merck Patent Gmbh |
Chirale binaphtol-verbindungen
|
US6884782B2
(en)
|
2000-11-08 |
2005-04-26 |
Amgen Inc. |
STAT modulators
|
CA2430363C
(fr)
|
2000-12-01 |
2010-04-13 |
Guilford Pharmaceuticals Inc. |
Composes et leurs utilisations
|
GB0102687D0
(en)
|
2001-02-02 |
2001-03-21 |
Pharmacia & Upjohn Spa |
Oxazolyl-pyrazole derivatives active as kinase inhibitors,process for their preparation and pharmaceutical compositions comprising them
|
US20100074949A1
(en)
|
2008-08-13 |
2010-03-25 |
William Rowe |
Pharmaceutical composition and administration thereof
|
US6531597B2
(en)
|
2001-02-13 |
2003-03-11 |
Hoffmann-La Roche Inc. |
Process for preparation of 2-phenyl acetic acid derivatives
|
US6962674B2
(en)
*
|
2001-02-28 |
2005-11-08 |
Varian, Inc. |
Dissolution test apparatus
|
EP1383799A4
(fr)
|
2001-04-10 |
2008-08-06 |
Transtech Pharma Inc |
Sondes, systemes et procedes pour la decouverte de medicaments
|
CA2444395C
(fr)
|
2001-04-23 |
2010-12-21 |
F. Hoffmann-La Roche Ag |
Utilisation d'antagonistes de recepteur de nk-1 contre l'hyperplasie benigne de la prostate
|
KR20040015716A
(ko)
|
2001-05-22 |
2004-02-19 |
뉴로젠 코포레이션 |
Crf1 조절자로서의 5-치환된-2-아릴피리딘
|
US20030083345A1
(en)
|
2001-07-10 |
2003-05-01 |
Torsten Hoffmann |
Method of treatment and/or prevention of brain, spinal or nerve injury
|
US6627646B2
(en)
|
2001-07-17 |
2003-09-30 |
Sepracor Inc. |
Norastemizole polymorphs
|
WO2003007945A1
(fr)
|
2001-07-20 |
2003-01-30 |
Boehringer Ingelheim (Canada) Ltd. |
Inhibiteurs de polymerase virale
|
AU2002322585A1
(en)
|
2001-07-20 |
2003-03-03 |
Adipogenix, Inc. |
Fat accumulation-modulating compounds
|
US7427623B2
(en)
|
2001-09-11 |
2008-09-23 |
Smithkline Beecham Corporation |
4-Amino-2,3-disubstituted thieno[2,3-d]pyrimidines and pharmacetical compositions thereof
|
PA8557501A1
(es)
|
2001-11-12 |
2003-06-30 |
Pfizer Prod Inc |
Benzamida, heteroarilamida y amidas inversas
|
JP2003155285A
(ja)
|
2001-11-19 |
2003-05-27 |
Toray Ind Inc |
環状含窒素誘導体
|
JP2003221386A
(ja)
|
2001-11-26 |
2003-08-05 |
Takeda Chem Ind Ltd |
二環性誘導体、その製造法およびその用途
|
US20030171411A1
(en)
|
2001-12-21 |
2003-09-11 |
Kodra Janos Tibor |
Amide derivatives as therapeutic agents
|
TW200307539A
(en)
|
2002-02-01 |
2003-12-16 |
Bristol Myers Squibb Co |
Cycloalkyl inhibitors of potassium channel function
|
TW200304820A
(en)
|
2002-03-25 |
2003-10-16 |
Avanir Pharmaceuticals |
Use of benzimidazole analogs in the treatment of cell proliferation
|
TW200403058A
(en)
|
2002-04-19 |
2004-03-01 |
Bristol Myers Squibb Co |
Heterocyclo inhibitors of potassium channel function
|
FR2840807B1
(fr)
|
2002-06-12 |
2005-03-11 |
|
Composition cosmetique de soin et/ou de maquillage, structuree par des polymeres silicones et des organogelateurs, sous forme rigide
|
GB0221443D0
(en)
|
2002-09-16 |
2002-10-23 |
Glaxo Group Ltd |
Pyridine derivates
|
US20050215614A1
(en)
|
2002-10-15 |
2005-09-29 |
Rigel Pharmaceuticals, Inc. |
Substituted indoles and their use as hcv inhibitors
|
WO2004041163A2
(fr)
|
2002-10-30 |
2004-05-21 |
Merck & Co., Inc. |
Composes de piperidinyl cyclopentyl aryl benzylamide modulateurs de l'activite du recepteur de chimiokine
|
WO2004040295A1
(fr)
*
|
2002-10-31 |
2004-05-13 |
Nanostream, Inc. |
Systemes de chromatographie de detection en parallele
|
WO2004054505A2
(fr)
|
2002-12-12 |
2004-07-01 |
Pharmacia Corporation |
Procede d'utilisation de composes d'aminocyanopyridine en tant qu'inhibiteurs de la proteine mapkap kinase-2
|
ATE506354T1
(de)
|
2003-01-06 |
2011-05-15 |
Lilly Co Eli |
Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren
|
EP2562158A1
(fr)
|
2003-02-10 |
2013-02-27 |
Vertex Pharmaceuticals Incorporated |
Procédés pour la préparation de n-hétéroaryl-N-aryl-aminés par mise en réaction d'un ester d'acide N-aryl-carbamique avec un halo-hétéroaryle et procédés analogues
|
US20050113423A1
(en)
|
2003-03-12 |
2005-05-26 |
Vangoor Frederick F. |
Modulators of ATP-binding cassette transporters
|
CA2523714A1
(fr)
|
2003-04-30 |
2004-11-18 |
The Institutes For Pharmaceutical Discovery, Llc |
Acides carboxyliques substitues
|
EP1646615B1
(fr)
|
2003-06-06 |
2009-08-26 |
Vertex Pharmaceuticals Incorporated |
Derives de pyrimidne utilises en tant que modulateurs de transporteurs de cassette de liaison a l'atp
|
GB0315111D0
(en)
|
2003-06-27 |
2003-07-30 |
Cancer Rec Tech Ltd |
Substituted 5-membered ring compounds and their use
|
AU2004253541B2
(en)
|
2003-06-27 |
2010-10-28 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. |
Amphiphilic pyridinium compounds, method of making and use thereof
|
JP2005053902A
(ja)
|
2003-07-18 |
2005-03-03 |
Nippon Nohyaku Co Ltd |
フェニルピリジン類、その中間体及びこれを有効成分とする除草剤
|
CN1878773A
(zh)
|
2003-09-05 |
2006-12-13 |
神经能质公司 |
作为crf1受体配位体的杂芳基稠合的吡啶,吡嗪及嘧啶
|
EP1664006A2
(fr)
|
2003-09-06 |
2006-06-07 |
Vertex Pharmaceuticals Incorporated |
Modulateurs de transporteurs a cassette de liaison a l'atp
|
US7534894B2
(en)
|
2003-09-25 |
2009-05-19 |
Wyeth |
Biphenyloxy-acids
|
US20050070718A1
(en)
|
2003-09-30 |
2005-03-31 |
Abbott Gmbh & Co. Kg |
Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them
|
RU2006115602A
(ru)
|
2003-10-08 |
2007-11-20 |
Вертекс Фармасьютикалз Инкорпорейтед (Us) |
Модуляторы переносчиков атф-связывающих кассет
|
FR2861304B1
(fr)
|
2003-10-23 |
2008-07-18 |
Univ Grenoble 1 |
Modulateurs des canaux cftr
|
GB0325956D0
(en)
|
2003-11-06 |
2003-12-10 |
Addex Pharmaceuticals Sa |
Novel compounds
|
RU2006120549A
(ru)
|
2003-11-14 |
2007-12-27 |
Вертекс Фармасьютикалз Инкорпорейтед (Us) |
Тиазолы и оксазолы, применяемые в качестве модуляторов транспортеров арт-связывающей кассеты
|
US20070142411A1
(en)
|
2003-11-19 |
2007-06-21 |
James Hagan |
Use of cyclooxygenase-2 selective inhibitors for the treatment of schizophrenic disorders
|
WO2005075435A1
(fr)
|
2004-01-30 |
2005-08-18 |
Vertex Pharmaceuticals Incorporated |
Modulateurs de transporteurs de type cassette de liaison a l'atp
|
US7977322B2
(en)
|
2004-08-20 |
2011-07-12 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-binding cassette transporters
|
CA2555409A1
(fr)
|
2004-02-19 |
2005-09-01 |
Banyu Pharmaceutical Co., Ltd. |
Nouveau derive de sulfonamide
|
ES2241496B1
(es)
|
2004-04-15 |
2006-12-01 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de piridina.
|
US20080015196A1
(en)
|
2004-04-16 |
2008-01-17 |
Neurogen Corporation |
Imidazopyrazines, Imidazopyridines, and Imidazopyrimidines as Crf1 Receptor Ligands
|
EP1740575A2
(fr)
|
2004-04-22 |
2007-01-10 |
Eli Lilly And Company |
Inhibiteurs de la bace
|
US7585885B2
(en)
|
2004-04-22 |
2009-09-08 |
Eli Lilly And Company |
Pyrrolidine derivatives useful as BACE inhibitors
|
WO2005117514A2
(fr)
|
2004-06-01 |
2005-12-15 |
Tm Bioscience Corporation |
Procédé de détection des mutations associées à la fibrose cystique
|
TWI547431B
(zh)
*
|
2004-06-09 |
2016-09-01 |
史密斯克萊美占公司 |
生產藥物之裝置及方法
|
US20140343098A1
(en)
|
2004-06-24 |
2014-11-20 |
Vertex Pharmaceuticals Incorporated |
Modulators of atp-binding cassette transporters
|
CA2810655C
(fr)
|
2004-06-24 |
2013-12-10 |
Vertex Pharmaceuticals Incorporated |
Modulateurs de transporteurs de cassette de liaison a l'atp
|
US8354427B2
(en)
|
2004-06-24 |
2013-01-15 |
Vertex Pharmaceutical Incorporated |
Modulators of ATP-binding cassette transporters
|
EP1781253A1
(fr)
|
2004-07-01 |
2007-05-09 |
Warner-Lambert Company LLC |
Preparation de compositions pharmaceutiques contenant des nanoparticules
|
AU2005269981A1
(en)
|
2004-07-02 |
2006-02-09 |
Bonck, John A |
Tablet for pulsed delivery
|
US8188277B2
(en)
|
2004-08-06 |
2012-05-29 |
Otsuka Pharmaceutical Co., Ltd. |
Aromatic compounds for suppressing the generation of collagen
|
AU2005289426A1
(en)
|
2004-09-27 |
2006-04-06 |
Amgen Inc. |
Substituted heterocyclic compounds and methods of use
|
CN101072758B
(zh)
|
2004-10-12 |
2013-07-31 |
阿斯利康(瑞典)有限公司 |
喹唑啉衍生物
|
CA2587461A1
(fr)
|
2004-11-15 |
2006-05-18 |
Pfizer Products Inc. |
Azabenzoxazoles pour traiter des troubles du systeme nerveux central
|
MX2007007133A
(es)
|
2004-12-15 |
2007-08-08 |
Dompe Pha R Ma Spa Res & Mfg |
Derivados de acido 2-arilpropionico y composiciones farmaceuticas que los contienen.
|
JP4790260B2
(ja)
|
2004-12-22 |
2011-10-12 |
出光興産株式会社 |
アントラセン誘導体を用いた有機エレクトロルミネッセンス素子
|
CA2595465C
(fr)
*
|
2005-01-25 |
2017-09-26 |
Bayer Cropscience Sa |
Procede d'analyse de l'acide phosphoreux, du fosetyl-al ou des deux simultanement
|
EP1844003A4
(fr)
|
2005-01-27 |
2010-09-22 |
Astrazeneca Ab |
Nouveaux composes biaromatiques, inhibiteurs du recepteur p2x7
|
US7888374B2
(en)
|
2005-01-28 |
2011-02-15 |
Abbott Laboratories |
Inhibitors of c-jun N-terminal kinases
|
JPWO2006082952A1
(ja)
|
2005-02-01 |
2008-06-26 |
武田薬品工業株式会社 |
アミド化合物
|
US8242149B2
(en)
|
2005-03-11 |
2012-08-14 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-binding cassette transporters
|
US7297700B2
(en)
|
2005-03-24 |
2007-11-20 |
Renovis, Inc. |
Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
|
EP1710246A1
(fr)
|
2005-04-08 |
2006-10-11 |
Schering Aktiengesellschaft |
Macrocycles de sulfoximine-pyrmidine et leurs sels correspondants, leurs procédé de fabrication, et leurs utilisation pharmaceutique contre le cancer
|
WO2006113704A2
(fr)
|
2005-04-18 |
2006-10-26 |
Neurogen Corporation |
Antagonistes cb1 heteroaryle substitue
|
BRPI0610850A2
(pt)
|
2005-04-19 |
2008-12-02 |
Bayer Pharmaceuticals Corp |
derivados de Ácido aril alquila, composiÇço farmacÊutica, medicamento, bem como uso dos referidos derivados
|
GB0510139D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B1
|
EP1891018B1
(fr)
|
2005-05-24 |
2011-11-16 |
Vertex Pharmaceuticals, Inc. |
Modulateurs des transporteurs de cassette de liaison a l'atp
|
CN101208088A
(zh)
|
2005-06-02 |
2008-06-25 |
拜尔农作物科学股份公司 |
苯基烷基取代的杂芳基衍生物
|
WO2006136829A2
(fr)
|
2005-06-21 |
2006-12-28 |
Astex Therapeutics Limited |
Composes pharmaceutiques
|
CN2856973Y
(zh)
*
|
2005-07-25 |
2007-01-10 |
中国环境科学研究院 |
旋转振荡装置
|
TW200738331A
(en)
*
|
2005-07-26 |
2007-10-16 |
Showa Denko Kk |
Method for analyzing low-molecular-weight compound in sample containing water-soluble polymer and low-molecular-weight compound
|
EP1912983B1
(fr)
|
2005-08-11 |
2011-06-08 |
Vertex Pharmaceuticals, Inc. |
Modulateurs du regulateur de la conductance transmembranaire de la fibrose kystique
|
ZA200802172B
(en)
|
2005-08-11 |
2009-06-24 |
Vertex Pharma |
Modulators of cystic fibrosis transmembrane conductance regulator
|
AR058805A1
(es)
|
2005-09-09 |
2008-02-27 |
Smithkline Beecham Corp |
Derivados biciclicos de piridina utiles como agentes antipsicoticos
|
CN101267808A
(zh)
|
2005-09-23 |
2008-09-17 |
弗·哈夫曼-拉罗切有限公司 |
新型制剂
|
JP2009511494A
(ja)
|
2005-10-06 |
2009-03-19 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Atp結合カセットトランスポーターのモジュレーター
|
EP2388258A1
(fr)
|
2005-10-19 |
2011-11-23 |
Grünenthal GmbH |
Nouveaux ligands du récepteur vanilloide et leur utilisation dans la production de médicaments
|
US20120232059A1
(en)
|
2005-11-08 |
2012-09-13 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-Binding Cassette Transporters
|
WO2007054480A1
(fr)
|
2005-11-08 |
2007-05-18 |
N.V. Organon |
Derives bisarylique de 2-(benzimidazol-1-yl)-acetamide et leur utilisation comme inhibiteurs du recepteur trpv1
|
SI2395002T1
(sl)
|
2005-11-08 |
2014-10-30 |
Vertex Pharmaceuticals Incorporated |
Farmacevtski sestavek, vsebujoč heterociklični modulator prenašalcev z ATP-vezavno kaseto
|
CN101326182B
(zh)
|
2005-12-05 |
2011-09-28 |
史密丝克莱恩比彻姆公司 |
2-嘧啶基吡唑并吡啶ErbB激酶抑制剂
|
AU2006331614A1
(en)
|
2005-12-24 |
2007-07-05 |
Vertex Pharmaceuticals Incorporated |
Quinolin- 4 - one derivatives as modulators of ABC transporters
|
EP1974212A1
(fr)
|
2005-12-27 |
2008-10-01 |
Vertex Pharmaceuticals Incorporated |
Composes utiles dans les bio-essais cftr et leurs procedes
|
CN103214450B
(zh)
|
2005-12-28 |
2016-10-05 |
弗特克斯药品有限公司 |
作为atp-结合盒转运蛋白调节剂的1-(苯并[d][1,3]间二氧杂环戊烯-5-基)-n-(苯基)环丙烷-甲酰胺衍生物
|
EP3708564A1
(fr)
|
2005-12-28 |
2020-09-16 |
Vertex Pharmaceuticals Incorporated |
Une forme solide de n-[2,4-bis(1,1-diméthyléthyl)-5-hydroxyphényl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
|
US7671221B2
(en)
|
2005-12-28 |
2010-03-02 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-Binding Cassette transporters
|
WO2007079257A2
(fr)
|
2005-12-30 |
2007-07-12 |
Caliper Life Sciences, Inc. |
Traitement de dissolution intégré et système de transfert d'échantillon
|
EP2007756B1
(fr)
|
2006-04-07 |
2015-08-26 |
Vertex Pharmaceuticals Incorporated |
Modulateurs des transporteurs de cassettes de liaison de l'atp
|
US10022352B2
(en)
|
2006-04-07 |
2018-07-17 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-binding cassette transporters
|
US7645789B2
(en)
|
2006-04-07 |
2010-01-12 |
Vertex Pharmaceuticals Incorporated |
Indole derivatives as CFTR modulators
|
ES2377840T3
(es)
|
2006-05-12 |
2012-04-02 |
Vertex Pharmaceuticals, Inc. |
Composiciones de N-[2,4-bis(1,1-dimetiletil)-5-hidroxifenil]-1,4-dihidro-4-oxoquinolina-3-carboxamida
|
EP1882948A2
(fr)
*
|
2006-07-28 |
2008-01-30 |
Qiagen GmbH |
Dispositif destiné au traitement d échantillons
|
US8563573B2
(en)
|
2007-11-02 |
2013-10-22 |
Vertex Pharmaceuticals Incorporated |
Azaindole derivatives as CFTR modulators
|
WO2008127399A2
(fr)
|
2006-11-03 |
2008-10-23 |
Vertex Pharmaceuticals Incorporated |
Dérivés d'azaindole comme modulateurs de cftr
|
US7754739B2
(en)
|
2007-05-09 |
2010-07-13 |
Vertex Pharmaceuticals Incorporated |
Modulators of CFTR
|
WO2008065068A2
(fr)
|
2006-11-27 |
2008-06-05 |
Novartis Ag |
Dihydroimidazoles substitués et leur utilisation dans le traitement de tumeurs
|
CN101206205B
(zh)
*
|
2006-12-22 |
2011-08-10 |
中国科学院大连化学物理研究所 |
微流量液相色谱在线大体积进样的方法和专用装置
|
CN101209399B
(zh)
*
|
2006-12-27 |
2010-07-28 |
中国科学院沈阳应用生态研究所 |
一种往复式振荡机样品安放与固定装置
|
CN101210906A
(zh)
*
|
2006-12-29 |
2008-07-02 |
电子科技大学 |
高通量自动化药物筛选实验检测系统
|
US20080260820A1
(en)
|
2007-04-19 |
2008-10-23 |
Gilles Borrelly |
Oral dosage formulations of protease-resistant polypeptides
|
JP5497633B2
(ja)
|
2007-05-09 |
2014-05-21 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Cftrのモジュレーター
|
CN101687883B
(zh)
|
2007-05-25 |
2012-05-23 |
沃泰克斯药物股份有限公司 |
囊性纤维化跨膜传导调节因子的调节剂
|
US20110177999A1
(en)
|
2007-08-09 |
2011-07-21 |
Vertex Pharmaceuticals Incorporated |
Therapeutic Combinations Useful in Treating CFTR Related Diseases
|
CA2696298C
(fr)
|
2007-08-24 |
2016-09-06 |
Vertex Pharmaceuticals Incorporated |
Modulateurs du regulateur de la conductance transmembranaire de la fibrose kystique
|
DE102007042754A1
(de)
|
2007-09-07 |
2009-03-12 |
Bayer Healthcare Ag |
Substituierte 6-Phenylnikotinsäuren und ihre Verwendung
|
EP2222304A2
(fr)
|
2007-09-14 |
2010-09-01 |
Vertex Pharmaceuticals Incorporated |
Formes solides de n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoleine-3-carboxamide
|
EP2201010B1
(fr)
|
2007-09-14 |
2013-11-06 |
Vertex Pharmaceuticals Incorporated |
Modulateurs du régulateur de la conductance transmembranaire de la mucoviscidose
|
FR2921657A1
(fr)
|
2007-09-28 |
2009-04-03 |
Sanofi Aventis Sa |
Derives de nicotinamide, leur preparation et leur application en therapeutique
|
ES2658064T3
(es)
|
2007-11-16 |
2018-03-08 |
Vertex Pharmaceuticals Incorporated |
Moduladores de isoquinolina de transportadores de casete de unión a ATP
|
DE102007058718A1
(de)
*
|
2007-12-06 |
2009-06-10 |
Erweka Gmbh |
Vorrichtung und Verfahren zur automatischen Freisetzung und Messung von Wirkstoffen aus einer Arzneizubereitung
|
SI2225230T1
(sl)
|
2007-12-07 |
2017-03-31 |
Vertex Pharmaceuticals Incorporated |
Trdne oblike 3-(6-(1-2,2-difluorobenzo(d)(1,3)dioxol-5-il)ciklopropan- karboksamido)-3-metilpiridin-2-il) benzojske kisline
|
EA201070699A1
(ru)
|
2007-12-07 |
2011-02-28 |
Вертекс Фармасьютикалз Инкорпорейтед |
Композиции 3-(6-(1-2,2-дифторбензо[d][1,3]диоксол-5-ил)циклопропанкарбоксамидо)-3-метилпиридин-2-ил)бензойной кислоты
|
US20100036130A1
(en)
|
2007-12-07 |
2010-02-11 |
Vertex Pharmaceuticals Incorporated |
Processes for producing cycloalkylcarboxamido-pyridine benzoic acids
|
PL2639223T3
(pl)
|
2007-12-07 |
2017-09-29 |
Vertex Pharmaceuticals Incorporated |
Sposób wytwarzania kwasów cykloalkilokarboksyamido-pirydyno-benzoesowych
|
EP2231671B1
(fr)
|
2007-12-13 |
2013-04-24 |
Vertex Pharmaceuticals Incorporated |
Modulateurs de régulateur de conductance transmembranaire de fibrose cystique
|
US20090173146A1
(en)
*
|
2008-01-07 |
2009-07-09 |
Matthias Pursch |
Temperature programmed low thermal mass fast liquid chromatography analysis system
|
CA2931134C
(fr)
|
2008-02-28 |
2019-07-30 |
Vertex Pharmaceuticals Incorporated |
Derives heteroaryles convenant comme modulateurs du cftr
|
JP5358588B2
(ja)
*
|
2008-02-29 |
2013-12-04 |
ウオーターズ・テクノロジーズ・コーポレイシヨン |
複数のプロセスストリームのクロマトグラフィによる監視および制御
|
EP2980077B1
(fr)
|
2008-03-31 |
2020-05-06 |
Vertex Pharmaceuticals Incorporated |
Dérivés de pyridyle comme modulateurs cftr
|
GB0813709D0
(en)
|
2008-07-26 |
2008-09-03 |
Univ Dundee |
Method and product
|
EP2328618B1
(fr)
|
2008-08-13 |
2017-11-29 |
Vertex Pharmaceuticals Incorporated |
Composition pharmaceutique de n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4- oxoquinoline-3-carboxamide et son administration
|
US20100256184A1
(en)
|
2008-08-13 |
2010-10-07 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical composition and administrations thereof
|
WO2010037066A2
(fr)
|
2008-09-29 |
2010-04-01 |
Vertex Pharmaceuticals Incorporated |
Unités posologiques d'acide 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-méthylpyridin-2-yl)benzoïque
|
NZ592687A
(en)
|
2008-10-23 |
2013-04-26 |
Vertex Pharma |
Modulators of cystic fibrosis transmembrane conductance regulator
|
US20110257223A1
(en)
|
2008-10-23 |
2011-10-20 |
Vertex Pharmaceuticals Incorporated |
Modulators of Cystic Fibrosis Transmembrane Conductance Regulator
|
NZ592504A
(en)
|
2008-10-23 |
2013-04-26 |
Vertex Pharma |
Solid forms of n-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide
|
SI2349263T1
(sl)
|
2008-10-23 |
2014-09-30 |
Vertex Pharmaceuticals Incorporated |
Modulatorji cistiäśno-fibroznega transmembranskega regulatorja prevodnosti
|
MX2011003982A
(es)
*
|
2008-10-31 |
2011-09-21 |
Bio Merieux Inc |
Métodos para la separación, caracterización y/o identificación de microorganismos usando espectroscopia.
|
UA104876C2
(uk)
|
2008-11-06 |
2014-03-25 |
Вертекс Фармасьютікалз Інкорпорейтед |
Модулятори atф-зв'язувальних касетних транспортерів
|
NZ609962A
(en)
|
2008-11-06 |
2014-11-28 |
Vertex Pharma |
Modulators of atp-binding cassette transporters
|
US8367660B2
(en)
|
2008-12-30 |
2013-02-05 |
Vertex Pharmaceuticals Incorporated |
Modulators of cystic fibrosis transmembrane conductance regulator
|
DK2408749T3
(en)
|
2009-03-20 |
2018-08-13 |
Vertex Pharma |
CYSTIC FIBROSE TRANSMEMBRAN CONDUCTOR CONTROLLER MODULATORS
|
KR101852173B1
(ko)
|
2009-03-20 |
2018-04-27 |
버텍스 파마슈티칼스 인코포레이티드 |
낭성 섬유증 막횡단 전도도 조절자의 조정자의 제조 방법
|
JP2012525895A
(ja)
|
2009-05-07 |
2012-10-25 |
ジーイーエイ・ファーマ・システムズ・リミテッド |
錠剤の製造モジュール及び錠剤の連続製造方法
|
US8053866B2
(en)
|
2009-08-06 |
2011-11-08 |
Freescale Semiconductor, Inc. |
Varactor structures
|
KR20120083416A
(ko)
|
2009-09-17 |
2012-07-25 |
버텍스 파마슈티칼스 인코포레이티드 |
아자비시클릭 화합물의 제조 방법
|
EP2486571A1
(fr)
*
|
2009-10-08 |
2012-08-15 |
GE Healthcare UK Limited |
Composants de chromatographie
|
EP2813227A1
(fr)
|
2009-10-22 |
2014-12-17 |
Vertex Pharmaceuticals Incorporated |
Compositions pour le traitement de la mucoviscidose et d'autres maladies chroniques
|
WO2011050220A1
(fr)
|
2009-10-23 |
2011-04-28 |
Vertex Pharmaceuticals Incorporated |
Formes solides de n-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-trifluorométhyl)phényl)-4-oxo-5-(trifluorométhyl)-1,4-dihydroquinoline-3-carboxamide
|
CA2778492A1
(fr)
|
2009-10-23 |
2011-04-28 |
Vertex Pharmaceuticals Incorporated |
Procede de preparation de modulateurs de regulateur de conductance transmembranaire de fibrose kystique
|
CN201586570U
(zh)
*
|
2010-02-03 |
2010-09-22 |
兰州大学 |
塑料离心过滤管
|
US8471029B2
(en)
|
2010-03-19 |
2013-06-25 |
Vertex Pharmaceutical Incorporated |
Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
|
US8802868B2
(en)
|
2010-03-25 |
2014-08-12 |
Vertex Pharmaceuticals Incorporated |
Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide
|
ES2604105T3
(es)
|
2010-03-25 |
2017-03-03 |
Vertex Pharmaceuticals Incorporated |
Formula cristalina de (r) -1 (2,2- difluorobenzo [d] [1,3] dioxol - 5yl) - n- (1- (2,3 - dihidroxipropil) - 6 - fluoro - 2- (1 - hydroxy-2-metilpropan-2il) -1h-indol-5il) cyclopropanecarboxamida
|
CN102933206A
(zh)
|
2010-04-07 |
2013-02-13 |
弗特克斯药品有限公司 |
3-(6-(1-(2,2-二氟苯并[d][1,3]二氧杂环戊烯-5-基)环丙烷甲酰胺基)-3-甲基吡啶-2-基)苯甲酸的固体形式
|
JP2013523833A
(ja)
|
2010-04-07 |
2013-06-17 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
3−(6−(1−(2,2−ジフルオロベンゾ[d][1,3]ジオキソール−5−イル)シクロプロパンカルボキサミド)−3−メチルピリジン−2−イル)安息香酸の医薬組成物およびその投与
|
CA2796602A1
(fr)
|
2010-04-22 |
2011-10-27 |
Vertex Pharmaceuticals Incorporated |
Compositions pharmaceutiques et leurs administrations
|
AU2011242452A1
(en)
|
2010-04-22 |
2012-11-08 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions and administrations thereof
|
MX342288B
(es)
|
2010-04-22 |
2016-09-23 |
Vertex Pharma |
Proceso para producir compuestos de cicloalquilcarboxamido-indol.
|
WO2011133956A1
(fr)
|
2010-04-22 |
2011-10-27 |
Vertex Pharmaceuticals Incorporated |
Compositions pharmaceutiques et leurs administrations
|
NZ603386A
(en)
|
2010-05-20 |
2015-02-27 |
Vertex Pharma |
Pharmaceutical compositions and administrations thereof
|
AR081920A1
(es)
|
2010-05-20 |
2012-10-31 |
Vertex Pharma |
Procesos de produccion de moduladores del regulador de conductancia transmembrana de fibrosis quistica
|
US8563593B2
(en)
|
2010-06-08 |
2013-10-22 |
Vertex Pharmaceuticals Incorporated |
Formulations of (R)-1-(2,2-difluorobenzo[D] [1,3] dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide
|
RU2013112937A
(ru)
|
2010-08-23 |
2014-09-27 |
Вертекс Фармасьютикалз Инкорпорейтед |
Фармацевтические композиции (r)-1-(2, 2-дифторбензо[d][1, 3]диоксол-5-ил)-n-(2, 3-дигидроксипропил)-6-фтор-2-(1-гидрокси-2-метилпропан-2-ил)-1н-индол-5-ил)циклопропанкарбоксамида и их применение
|
RU2013113627A
(ru)
|
2010-08-27 |
2014-10-10 |
Вертекс Фармасьютикалз Инкорпорейтед |
Фармацевтическая композиция и ее введения
|
CN102058889A
(zh)
|
2010-11-05 |
2011-05-18 |
王定豪 |
包含抗凝血类药物的分散片及其应用
|
US8802700B2
(en)
|
2010-12-10 |
2014-08-12 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-Binding Cassette transporters
|
KR101387872B1
(ko)
|
2011-05-11 |
2014-04-22 |
경상대학교산학협력단 |
생물 검체 내 카페인 및 카테킨을 동시분석하는 방법
|
CN102507770A
(zh)
*
|
2011-10-25 |
2012-06-20 |
中国检验检疫科学研究院 |
检测化妆品中六氯酚的高效液相色谱法
|
EP2773349A1
(fr)
|
2011-11-02 |
2014-09-10 |
Vertex Pharmaceuticals Incorporated |
Utilisation de (n-[2,4-bis(1,1-diméthyléthyl)-5-hydroxyphényl]-1,4-dihydro-4-oxoquinoline-3-carboxamide) pour le traitement des maladies associées au gène cftr
|
US20140127901A1
(en)
|
2012-11-08 |
2014-05-08 |
Taiwan Semiconductor Manufacturing Company, Ltd. |
Low-k damage free integration scheme for copper interconnects
|
IN2014KN00885A
(fr)
|
2011-11-08 |
2015-10-02 |
Vertex Pharma |
|
SG10201606135TA
(en)
|
2012-01-25 |
2016-09-29 |
Vertex Pharma |
Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
|
CN104470518A
(zh)
|
2012-02-27 |
2015-03-25 |
沃泰克斯药物股份有限公司 |
药物组合物及其施用
|
US8674108B2
(en)
|
2012-04-20 |
2014-03-18 |
Vertex Pharmaceuticals Incorporated |
Solid forms of N-[2,4-bis(1,1-dimethylethy)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
|
JP2013253790A
(ja)
*
|
2012-06-05 |
2013-12-19 |
Chube Univ |
ニバレノールの分析法
|
EP2858645A1
(fr)
|
2012-06-08 |
2015-04-15 |
Vertex Pharmaceuticals Incorporated |
Compositions pharmaceutiques pour le traitement des troubles à médiation par cftr
|
US9012496B2
(en)
|
2012-07-16 |
2015-04-21 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions of (R)-1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide and administration thereof
|
CN102788834B
(zh)
*
|
2012-08-29 |
2015-06-03 |
浙江农林大学 |
水果可溶性糖快速测定方法
|
KR101455694B1
(ko)
|
2012-09-18 |
2014-11-03 |
학교법인 선목학원 |
에틸아세테이트 및 아세토니트릴의 유기용매 혼합액을 이용한 액체-액체 추출법을 포함하는 약물 검출법
|
US20140092376A1
(en)
|
2012-10-01 |
2014-04-03 |
Momentive Performance Materials, Inc. |
Container and method for in-line analysis of protein compositions
|
JP6302923B2
(ja)
|
2012-11-02 |
2018-03-28 |
バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated |
Cftrが媒介する疾患の処置のための医薬組成物
|
US9636301B2
(en)
*
|
2012-12-04 |
2017-05-02 |
Arbutus Biopharma Corporation |
In vitro release assay for liposome encapsulated vincristine
|
US20140221424A1
(en)
|
2013-01-30 |
2014-08-07 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions for use in the treatment of cystic fibrosis
|
CN103264029B
(zh)
*
|
2013-05-06 |
2015-03-25 |
深圳市华星光电技术有限公司 |
一种色谱分析样品瓶清洗装置及清洗方法
|
CN103743826B
(zh)
*
|
2013-08-28 |
2015-12-02 |
合肥久诺医药科技有限公司 |
一种阿齐沙坦的高效液相色谱分析方法
|
CN103822976B
(zh)
*
|
2013-10-15 |
2015-05-27 |
辽宁省食品药品检验所 |
一种测定化妆品中4-甲氧基水杨酸钾的方法
|
ES2957761T3
(es)
|
2014-04-15 |
2024-01-25 |
Vertex Pharma |
Composiciones farmacéuticas para el tratamiento de enfermedades mediadas por el regulador de la conductancia transmembrana de fibrosis quística
|
CN104090038B
(zh)
*
|
2014-07-07 |
2015-09-30 |
黄宏南 |
一种直接测定冬虫夏草产品中冬虫夏草多糖肽含量的方法
|
CN104122346B
(zh)
*
|
2014-07-31 |
2016-03-16 |
国家烟草质量监督检验中心 |
一种水基胶中尿素含量的测定方法
|
CN104122345B
(zh)
*
|
2014-07-31 |
2015-08-12 |
国家烟草质量监督检验中心 |
烟用纸中1,1,1-三羟甲基丙烷的测定方法
|
RU2020134082A
(ru)
|
2014-10-06 |
2020-11-27 |
Вертекс Фармасьютикалз Инкорпорейтед |
Модуляторы регулятора трансмембранной проводимости при муковисцидозе
|
JP6746569B2
(ja)
|
2014-10-07 |
2020-08-26 |
バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated |
嚢胞性線維症膜貫通コンダクタンス制御因子のモジュレーターの共結晶
|
MA41031A
(fr)
|
2014-11-26 |
2017-10-03 |
Catabasis Pharmaceuticals Inc |
Conjugués cystéamine-acide gras et leur utilisation comme activateurs de l'autophagie
|
WO2016086136A1
(fr)
|
2014-11-26 |
2016-06-02 |
Catabasis Pharmaceuticals, Inc. |
Conjugués de cystéamine d'acide gras de modulateurs de cftr et leur utilisation dans le traitement de troubles médicaux
|
EP3226861A2
(fr)
|
2014-12-05 |
2017-10-11 |
Centre National de la Recherche Scientifique (CNRS) |
Composés pour le traitement de la mucoviscidose
|
CA2974900A1
(fr)
|
2015-01-26 |
2016-08-04 |
Rigel Pharmaceuticals, Inc. |
Tretrazolones utilisees comme bioisosteres d'acide carboxylique
|
UY36680A
(es)
|
2015-05-19 |
2016-12-30 |
Glaxosmithkline Ip Dev Ltd |
Amidas heterocíclicas como inhibidores de quinasa
|
CN105890945A
(zh)
*
|
2016-04-01 |
2016-08-24 |
中国热带农业科学院分析测试中心 |
超声离心渗液进样快速测定土壤中速效钾的方法
|